Focal Therapy for Prostate Cancer: The Impact on Sexual Function
Focal therapy (FT) has emerged as a potential treatment for localized prostate cancer (PCa) with encouraging functional outcomes. According to the compelling evidence based on meta-analyses and recent trials, erectile function (EF) is mostly retained at 6 and 12 months after FT when compared to base...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Uro |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4397/2/4/25 |